Naloxone-induced abdominal distress in the horse
| Autor: | Jena G. Hamra, Cleo A. Bagwell, Steven G. Kamerling |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
Tachycardia
Diarrhea medicine.medical_specialty Colic medicine.drug_class Gastrointestinal Diseases (+)-Naloxone Heart Rate Internal medicine medicine Animals Endorphins Horses Opioid peptide Defecation Endogenous opioid Behavior Animal business.industry Naloxone Respiration Horse General Medicine Syndrome Pathophysiology Abdominal Pain Endocrinology Anesthesia Horse Diseases Yawning medicine.symptom business Opioid antagonist |
| Zdroj: | Equine veterinary journal. 22(4) |
| ISSN: | 0425-1644 |
| Popis: | Endogenous opioid peptides have been implicated in the regulation of pain perception, behaviour, gastrointestinal activity and other physiological responses. However, the functional role of these peptides in the horse has yet to be elucidated. The opioid antagonist, naloxone, is often administered to infer endogenous opioid effects. In the present study, naloxone (0.75 mg/kg bodyweight) was administered to eight Thoroughbred racehorses and a number of behavioural and autonomic responses were measured. Naloxone produced rapid onset diarrhoea, restlessness, abdominal checking, tachycardia, tachypnoea, paradoxical yawning and diaphoresis. These responses described an acute abdominal distress syndrome similar to spasmodic colic. Results from this study suggest that, in the horse, endogenous opioids: 1) influence behaviour, 2) modify intestinal activity and sensation, and 3) if perturbed, may be involved in pathophysiology of colic. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text